Brunetti-Pierri, N., Grove, N. C., Zuo, Y., Edwards, R., Palmer, D., Cerullo, V., . . . Ng, P. (2009). Bioengineered Factor IX Molecules with Increased Catalytic Activity Improve the Therapeutic Index of Gene Therapy Vectors for Hemophilia B. Mary Ann Liebert, Inc.

Brunetti-Pierri, Nicola, Nathan C. Grove, Yu Zuo, Rachel Edwards, Donna Palmer, Vincenzo Cerullo, Jun Teruya, und Philip Ng. Bioengineered Factor IX Molecules With Increased Catalytic Activity Improve the Therapeutic Index of Gene Therapy Vectors for Hemophilia B. Mary Ann Liebert, Inc, 2009.

Brunetti-Pierri, Nicola, et al. Bioengineered Factor IX Molecules With Increased Catalytic Activity Improve the Therapeutic Index of Gene Therapy Vectors for Hemophilia B. Mary Ann Liebert, Inc, 2009.